PTC Therapeutics, Inc. (PTCT)

NMS – Real Time Price. Currency in USD

75.02

-1.83 (-2.38%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

1.73B

807M

938M

699M

Cost of goods sold

-72M

-118M

-288M

-161M

Gross Profit

1.66B

689M

650M

538M

Operating expenses (excl. COGS)

-802M

-835M

-999M

-977M

Operating Income

857M

-147M

-349M

-440M

Non-operating income, total

-160M

-216M

-347M

-148M

Pretax income

697M

-363M

-696M

-587M

Equity in earnings

Taxes

-14M

-176K

70M

28M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

683M

-363M

-627M

-559M

PTC Therapeutics, Inc. (PTCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

PTC Therapeutics, Inc. (PTCT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

PTC Therapeutics, Inc. (PTCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

PTC Therapeutics, Inc. (PTCT)

Income Statement (Annual)

Income Statement (Annual)